What I Am Buying Today.

[MrFortune]

(01-07-2022, 02:59 PM)fenders53 Wrote:

(01-07-2022, 02:44 PM)Mr1share Wrote: Added SBUX, OHI, BX and O

New positions in YUM, EPD, IRM

I agree SBUX is a buy at these levels. Ken Do obviously hasn't waited in line at one At a 25 forward PE not that expensive at all. The dividend is just a bonus.

Trimmed CVX, XOM and DVN, and sold out of T (Actually made $220 on it lol)

Have puts in MRNA and BNTX (Covid vacs run is done)

Like Fenders staying away from Tech. Rich valuations still. Chips next to get hit big. AVGO has lost $60 in 2 days lol

Ok that's enough for today.

Yeah Starbucks isn't going away.  My wife and daughter love the place. Probably not a table pounding buy but you rarely get burnt buying a SBUX dip. 

You won't get crushed shorting the Vax but I'm not sure it's an easy target yet.  We'll see I guess.  My wife owns some PFE but Covid isn't their only game.  Just their cash cow for at least a few more quarters. 

I am going to keep nibbling the NAS and it will work out because I don't care how long it takes, but it's a real crap shoot picking an individual name right here.  I am playing with AMD puts and I'll likely get sucked in.  I'm good with that but of course I want to pay near market value after the big premiums play out.

PFE is a but different then MRNA and BNTX but it only ran because the vaccines. I would be hesitant to own PFE at these levels now.

SBUX is a stock you buy and don't touch. I added some as well. It's like the Amazon of coffee   It's a much own 

MRNA will probably head to that $150 area. Not a stock I want to own 

AMD don't want to own either. Great products but it has ran way too much. I didn't even but when it was $10, so I'm sure not going to buy now lol. I know completely different company but I would rather own boring INTC here in this crazy over valued market. Plus you get a dividend. AMD has been all hype and I'm afraid like most tech it will go much lower when the big shots had enough. They ran it up from $104 to $161 on nothing more then short covering. 41 PE still way too high. 

I did add some JEPI and new position in HUM and (I listened to the conference call. Not all that bad. While HUM’s enrollment update was disappointing, they noted they priced conservatively which may be driving the reduced enrollment growth. That said, they left remainder of 2022 EPS outlook unchanged. We will watch to see in coming weeks if management continues to describe the 11% growth rate as the floor for EPS growth later this year. To me this is temporary and its a buying opportunity